IP Library Granted Patent US 9,987,115
Granted Patent B2
US 9,987,115 · App. 14/007,646 · Granted Jun 5, 2018

Film encapsulated pelvic implant system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,987,115
App. No.
14/007,646
Granted
Jun 5, 2018
Kind
B2
Abstract

Various embodiments of an implant devices and systems are provided. The implant devices can include a mesh or implant encapsulated or otherwise coated, in whole or in part, with a film or coating. The coating or film can include methylcellulose or ethylcellulose to provide tissue regeneration as a hydrogel, while also providing a stiff polymer film when dry.

Claims (26)

1. An implant device for treating a pelvic condition, comprising: a mesh implant device having, a plurality of members defining a plurality of openings, the mesh implant device adapted to support pelvic tissue of a patient; and a methylcellulose film coupled to the plurality of members, the methylcellulose film including a flexible polymer coating before the mesh implant is implanted into a body of the patient, the methylcellulose having a first stiffness before the mesh implant is implanted into the body of the patient, the methylcellulose film configured to absorb moisture after the mesh implant is implanted into the body of the patient, the methylcellulose film configured to have a hydrogel in response to the methylcellulose film absorbing moisture, the methylcellulose film configured to have a second stiffness in response to the methylcellulose film absorbing moisture, the second stiffness being less than the first stiffness.

2. The implant device of claim 1 , wherein the mesh implant device is constructed at least in part of a polypropylene material.

3. The implant device of claim 1 , further including one or more tissue anchoring devices.

4. The implant device of claim 1 , wherein the methylcellulose film includes a hydrophilic polymer.

5. The implant device of claim 1 , wherein the methylcellulose film fills in one or more of the plurality of openings of the mesh implant device.

6. The implant device of claim 1 , wherein the plurality of members are a plurality of woven or knitted filament members.

7. The implant device of claim 1 , wherein the plurality of members are a plurality of strut members defining a unitary mesh implant device.

8. The implant device of claim 1 , wherein the methylcellulose film encapsulates a limited portion of the mesh implant device to define at least one absorbable film band for the mesh implant device.

9. The implant device of claim 1 , wherein the mesh implant device is generally elongate and is adapted to support a urethra to treat incontinence.

10. The implant device of claim 1 , wherein the mesh implant device is adapted to support pelvic tissue in treating vaginal prolapse.

11. The implant device of claim 1 , wherein the mesh implant device is adapted to support tissue for treating fecal incontinence.

12. A method of treating a pelvic disorder in a patient, comprising:

providing a mesh implant having a support portion adapted to support pelvic tissue, the mesh implant further having a plurality of members defining a plurality of openings, the plurality of members of the mesh implant being encapsulated with a methylcellulose film to place the mesh implant within a tensioned state, the mesh implant having a first length in the tensioned state; and

deploying the mesh implant having the methylcellulose film to a target site within the patient, the support portion providing support to the pelvic tissue; and

absorbing moisture by the methylcellulose film and lengthening the mesh implant to a second length in response to the methylcellulose film absorbing moisture, wherein, in response to the methylcellulose film absorbing moisture, tension is removed, and the mesh implant transitions from the tensioned state to a natural state.

13. The method of claim 12 , wherein the mesh implant is constructed at least in part of a polypropylene material.

14. The method of claim 12 , wherein the mesh implant further includes one or more tissue anchoring devices.

15. The method of claim 12 , wherein the methylcellulose film fills in one or more of the plurality of openings of the mesh implant.

16. The method of claim 12 , wherein the plurality of members are a plurality of woven or knitted filament members.

17. The method of claim 12 , wherein the plurality of members are a plurality of strut members defining a unitary mesh implant.

18. The method of claim 12 , wherein the mesh implant is generally elongate and is adapted to support a urethra to treat incontinence.

19. The method of claim 12 , wherein the mesh implant is adapted to support pelvic tissue in treating vaginal prolapse.

20. An implant device for treating a pelvic condition, comprising:

a mesh implant device having a plurality of members defining a plurality of openings, the mesh implant device adapted to support pelvic tissue of a patient; and

a methylcellulose film encapsulating the plurality of members, the methylcellulose film including a translucent flexible polymer coating before the mesh implant is implanted into a body of the patient, the methylcellulose film having a first stiffness before the mesh implant is implanted into the body of the patient, the mesh implant device having a first length before the mesh implant device is implanted into the body of the patient,

the methylcellulose film configured to absorb moisture after the methylcellulose film is inserted into the body of the patient, the methylcellulose film configured to have a hydrogel in response to the methylcellulose film absorbing moisture, the methylcellulose film configured to have a second stiffness in response to the methylcellulose film absorbing moisture, the second stiffness being less than the first stiffness, the mesh implant device configured to have a second length in response to the methylcellulose film absorbing moisture, the second length being greater than the first length.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2013
From: ARCAND, BENJAMIN Y.; KAZMIERKOSKI, JAMES A.; HACKER, DEAN W.; ROLFES MEYERING, EMILY
To: AMS RESEARCH CORPORATION
Reel/Frame 031617/0150 →